Posaconazole
Posaconazole is an approved active ingredient.
Pharmaceutical drug
What it is used for
- Aspergillosis
- Coccidioidomycosis
- Neutropenia
- Candidiasis
- Fungal infectious disease
Posaconazole is an azole antifungal indicated as follows: Posaconazole delayed-release tablets are indicated for the treatment of invasive aspergillosis in adults and pediatric patients 2 years of age and older who weigh greater than 40 kg.
Noxafil concentrate for solution for infusion is indicated for use in the treatment of the following invasive fungal infections in adult and paediatric patients from 2 years of age: Invasive aspergillosis Fusariosis in patients with disease that is refractory to amphotericin B…
How it works
- Cytochrome P450 51 inhibitor
Common side effects
The most commonly reported adverse reactions (>2% of patients) leading to treatment discontinuation were septic shock, respiratory failure, and bronchopulmonary aspergillosis in the Noxafil group, and septic shock and acute myeloid leukemia in the voriconazole group.
Who should not take it
Known hypersensitivity to posaconazole or other azole antifungal agents.
Pregnancy and breastfeeding
Based on findings from animal data, posaconazole may cause fetal harm when administered to pregnant women.
Interactions
- Atorvastatin — rhabdomyolysis, muscular disease
- Bedaquiline — long QT syndrome
- Domperidone — long QT syndrome
- Famotidine — long QT syndrome
- Ivabradine — long QT syndrome
- Nifedipine — hypotension, sinus bradycardia, acute kidney injury
- Nilotinib — long QT syndrome
- Quetiapine — long QT syndrome
- Ritonavir — long QT syndrome
- Saquinavir — long QT syndrome
- Simvastatin — rhabdomyolysis, muscular disease
- Sufentanil — central respiratory depression
- Sunitinib — long QT syndrome
- Tolterodine — long QT syndrome
- Vardenafil — long QT syndrome
- Alprazolam
- Atazanavir
- Ceftazidime
- Ciclosporin
- Cimetidine
- Darunavir
- Digoxin
- Diltiazem
- Efavirenz
- Erlotinib
- Esomeprazole
- Felodipine
- Hydrocortisone
- Lovastatin
- Metoclopramide
Brand names
United States
Noxafil · Noxafil Powdermix KIT
European Union
Noxafil · Posaconazole Accord · Posaconazole AHCL
Canada
Apo-Posaconazole · Gln-Posaconazole · Jamp Posaconazole · Mint-Posaconazole · Posanol · Sandoz Posaconazole · Taro-Posaconazole
Other trade names
Posaconazole sp
Approval status
- US Food and Drug Administration
- prescription · since 2006
- European Medicines Agency
- authorised · since 2005
- Health Canada
- prescription · marketed
- First approval anywhere
- 2005
Codes
- ATC
- J02AC04
- RxNorm CUI
- 282446
- ChEMBL
- CHEMBL1397
- PubChem CID
- 468595
- UNII
- 6TK1G07BHZ
- Wikidata
- Q906453
Frequently asked questions
What is Posaconazole used for?
Posaconazole is used for: Aspergillosis, Coccidioidomycosis, Neutropenia, Candidiasis, and Fungal infectious disease.
What are the brand names of Posaconazole?
Brand names of Posaconazole include Noxafil, Noxafil Powdermix KIT, Posaconazole Accord, Posaconazole AHCL, Apo-Posaconazole, Gln-Posaconazole, Jamp Posaconazole, and Mint-Posaconazole.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)